Clinical Trial Detail

NCT ID NCT01892371
Title Quizartinib With Azacitidine or Cytarabine in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

chronic myeloid leukemia

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Azacitidine + Quizartinib

Cytarabine + Quizartinib

Age Groups: adult senior

Additional content available in CKB BOOST